Does Rallies show Form 4 insider transactions for MLSS?

Yes. Rallies tracks MLSS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MLSS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MLSS. It does not provide personalized investment advice.

MLSS (Milestone Scientific, Inc. Common Stock) Stock Analysis - Insider Trades

Milestone Scientific, Inc. Common Stock (MLSS) is a publicly traded Healthcare sector company. As of May 21, 2026, MLSS trades at $0.38 with a market cap of $28.62M and a P/E ratio of -5.67. MLSS moved +14.99% today. Year to date, MLSS is +32.60%; over the trailing twelve months it is -62.00%. Its 52-week range spans $0.22 to $1.39. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces MLSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MLSS stock inside the company?

Recent MLSS insider activity includes BP4 S.r.l. sold 100.00K, BP4 S.r.l. sold 80.00K, BP4 S.r.l. sold 14.43K, BP4 S.r.l. sold 40.00K, and BP4 S.r.l. sold 24.03K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MLSS Key Metrics

Key financial metrics for MLSS
Metric	Value
Price	$0.38
Market Cap	$28.62M
P/E Ratio	-5.67
EPS	$-0.07
Dividend Yield	0.00%
52-Week High	$1.39
52-Week Low	$0.22
Volume	3.37K
Avg Volume	0
Revenue (TTM)	$8.97M
Net Income	$-5.72M
Gross Margin	71.40%

Recent MLSS Insider Trades

BP4 S.r.l. sold 100.00K (~$43.98K) on Oct 24, 2025.
BP4 S.r.l. sold 80.00K (~$34.42K) on Oct 23, 2025.
BP4 S.r.l. sold 14.43K (~$6.49K) on Oct 22, 2025.
BP4 S.r.l. sold 40.00K (~$17.59K) on Oct 21, 2025.
BP4 S.r.l. sold 24.03K (~$10.88K) on Oct 20, 2025.

Latest MLSS News

Milestone Scientific Cuts Q1 Operating Loss to $828K as Medical Sales Double — May 14, 2026
Milestone’s CompuFlo Advisor Program Expands to Seven States, Targets Medicare Reimbursement Growth — May 7, 2026
Milestone Scientific Raises $2.15M in 7.96M-Unit Private Placement with Warrants — Apr 21, 2026
Milestone Scientific Projects 400% CompuFlo Sales Growth, $9.8M–$10.2M 2026 Revenue — Mar 31, 2026
Milestone Scientific’s Q4 Preview Sees $2.31M Revenue, -$0.02 EPS Estimate — Mar 31, 2026

MLSS Analyst Consensus

1 analysts cover MLSS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.

Common questions about MLSS

Who is trading MLSS stock inside the company?: Recent MLSS insider activity includes BP4 S.r.l. sold 100.00K, BP4 S.r.l. sold 80.00K, BP4 S.r.l. sold 14.43K, BP4 S.r.l. sold 40.00K, and BP4 S.r.l. sold 24.03K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MLSS?: Yes. Rallies tracks MLSS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MLSS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MLSS. It does not provide personalized investment advice.